Aspen Pharmacare Quick Ratio 2017-2025 | APNHY
Historical quick ratio values for Aspen Pharmacare (APNHY) over the last 10 years.
| Aspen Pharmacare Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-12-31 | $2.45B | $0.92B | 2.66 |
| 2025-06-30 | $1.14B | $0.96B | 1.18 |
| 2024-12-31 | $1.20B | $0.96B | 1.25 |
| 2024-06-30 | $1.40B | $1.30B | 1.07 |
| 2023-12-31 | $1.34B | $1.23B | 1.09 |
| 2023-06-30 | $1.40B | $1.31B | 1.08 |
| 2022-12-31 | $1.25B | $0.94B | 1.33 |
| 2022-06-30 | $1.24B | $1.54B | 0.80 |
| 2021-12-31 | $1.37B | $1.21B | 1.13 |
| 2021-06-30 | $1.26B | $2.40B | 0.53 |
| 2020-12-31 | $1.87B | $1.29B | 1.45 |
| 2020-06-30 | $1.31B | $1.16B | 1.12 |
| 2019-06-30 | $1.52B | $1.41B | 1.07 |
| 2018-12-31 | $2.08B | $1.55B | 1.34 |
| 2018-06-30 | $2.01B | $2.20B | 0.91 |
| 2017-12-31 | $1.65B | $2.97B | 0.56 |
| 2017-06-30 | $1.80B | $2.56B | 0.70 |
| 2016-12-31 | $1.66B | $1.76B | 0.94 |
| 2016-06-30 | $1.58B | $1.46B | 1.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $3.708B | $2.388B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |